UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 16, 2006
QuadraMed Corporation
(Exact name of registrant as specified in its charter)
Delaware | 001-32283 | 52-1992861 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
12110 Sunset Hills Road, Suite 600, Reston, VA 20190
(Address of principal executive office and zip code)
(703) 709-2300
(Registrants telephone number, including area code)
(Not Applicable)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 8.01 | OTHER EVENTS. | 3 | ||
SIGNATURES | 4 |
2
Lawrence P. English, a member of QuadraMeds board of directors, has established a pre-arranged trading plan in accordance with SEC Rule 10b5-1. Mr. English currently is the beneficial owner of 2,660,500 shares of QuadraMed common stock, of which 1,992,000 shares of common stock are issuable upon the exercise of currently exercisable options. Under the pre-arranged trading plan, up to 668,500 shares of QuadraMeds common stock held by Mr. English will be sold beginning in January 2007 and may continue over the ensuing twelve months. Mr. English entered into the pre-arranged trading plan for personal financial planning purposes.
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 17, 2006
QuadraMed Corporation |
/s/ David L. Piazza |
David L. Piazza, Executive Vice President and Chief Financial Officer |
4